The ahead study: effectiveness interim results after one year of observation, an analysis of the European patients cohort

被引：0
|
作者：
Oldenburg, J. [1 ]
Tsakiris, D. [2 ]
Hermans, C. [3 ]
Liesner, R. [4 ]
Mazzucconi, M. G. [5 ]
Parra, R. [6 ]
Steinitz, K. [7 ]
Abad-Franch, L. [8 ]
Loew-Baselli, A. [9 ]
机构：
[1] Bonn Univ Clin, Inst Expt Hematol & Transfus Med, Bonn, Germany
[2] Univ Basel Hosp, Diagnost Hematol, CH-4031 Basel, Switzerland
[3] St Luc Univ Hosp, Haemophilia Clin, Brussels, Belgium
[4] Great Ormond St Hosp Sick Children, Haemophilia Comprehens Care Ctr, London WC1N 3JH, England
[5] Univ Roma La Sapienza, Policlin Umberto 1, I-00185 Rome, Italy
[6] Hosp Univ Vall dHebron, Barcelona, Spain
[7] Baxter Healthcare Corp, Baxter Innovat GmbH, Vienna, Austria
[8] Baxter Healthcare SA, Zurich, Switzerland
[9] Baxter Innovat GmbH, Vienna, Austria
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO243-TUE
引用
收藏
页码：596 / 596
页数：1
相关论文
共 50 条
  • [21] Morbidity and accidents in patients with epilepsy: Results of a European cohort study
    Beghi, E
    Cornaggia, C
    EPILEPSIA, 2002, 43 (09) : 1076 - 1083
  • [22] A multicenter, prospective, observational cohort studies in incident dialysis patients:: Interim analysis results from the ANSWER study
    García, RP
    Martín-Malo, A
    Fort, J
    Cuevas, X
    García, F
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V296 - V296
  • [23] Upadacitinib improves symptomatic, biochemical, and intestinal ultrasound parameters in active UC patients up to one year after treatment induction - one year interim results from the IBD-DACH study EUROPE
    Zeissig, S.
    Schmelz, R.
    Helwig, U.
    Moschen, A. R.
    Greuter, T.
    Fischer, I
    Hammer, L.
    Rath, S.
    Kucharzik, T.
    Maaser, C.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1650 - i1651
  • [24] Fremanezumab Long-Term Efficacy and Safety: Interim Results of a One-Year Study
    Goadsby, P.
    Yeung, P. P.
    Blankenbiller, T.
    Grozinski-Wolff, M.
    Yang, R.
    Ma, Y.
    Ning, X.
    Aycardi, E.
    HEADACHE, 2018, 58 : 166 - 166
  • [25] MORTALITY OF HEART INFARCTION PATIENTS IN LONGITUDINAL SECTIONAL STUDY (LUTERIM RESULTS AFTER 3 YEAR OBSERVATION)
    STOCKSMEIER, U
    WINTER, H
    MULLER, W
    MAAK, N
    ZEITSCHRIFT FUR KARDIOLOGIE, 1974, : 28 - 28
  • [26] Joint Health Outcomes in Patients with Hemophilia A Receiving Antihemophilic Factor (Recombinant) in a Real-world Setting: Results of a 6-year Interim Analysis of the AHEAD International Study
    Khair, Kate
    Ozelo, Margareth
    Klamroth, Robert
    Guillet, Benoit
    Tsakiris, Dimitrios
    Botha, Jaco
    Fernandez, Alejandro
    Tang, Leilei
    Oldenburg, Johannes
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 74 - 74
  • [27] One-year intestinal ultrasound improvements in UC patients on biologic or JAKi therapy - interim results of the TRUST BEYOND study
    Kucharzik, T.
    Helwig, U.
    Seibold, F.
    Biedermann, L.
    Hoegenauer, C.
    Fischer, I.
    Hammer, L.
    Rath, S.
    Maaser, C.
    SWISS MEDICAL WEEKLY, 2023, 153 : 9S - 9S
  • [28] Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study)
    Rocino, A.
    Cortesi, P. A.
    Scalone, L.
    Mantovani, L. G.
    Crea, R.
    Gringeri, A.
    HAEMOPHILIA, 2016, 22 (01) : 96 - 102
  • [29] Year one interim analysis results of the Phase IIIb CHORDS study evaluating ocrelizumab effectiveness and safety in patients with relapsing-remitting multiple sclerosis who had suboptimal response with prior diseasemodifying treatments
    Leist, T. P.
    Reder, A. T.
    Bermel, R.
    Weinstock-Guttman, B.
    Freedman, M. S.
    Cutter, G.
    Stankiewicz, J.
    Zheng, H.
    Musch, B.
    Csoboth, C.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 318 - 319
  • [30] Cost-effectiveness study of olanzapine pamoate: Mirror-image analysis after one year
    Potaufeu, J.
    Langree, B.
    Drapier, D.
    Burgot, G.
    Marie, N.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2019, 45 (03): : 232 - 238
12345